+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 1Year - 25Years
All Genders
ID07685457

Safety and Effectiveness Study of Virus-Specific T-Cell Therapy in Children and Young Adults With Viral Infections After Stem Cell Transplant

Led by LucasBio · Updated on 2026-07-06

6

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of a therapy called Multi-Virus Specific T cells LB-DTK-MV in children and young adults aged 1 to 25 years who have systemic viral infections such as CMV, EBV, and BKV after receiving allogeneic hematopoietic stem cell transplantation. The study aims to determine the maximum tolerated dose of LB-DTK-MV, identify any adverse events within two weeks after the second infusion, and assess reductions in viral loads and improvements in symptoms within the same timeframe. Participants will receive two intravenous infusions of LB-DTK-MV at either a low dose 1x107m2 or a high dose 2x107m2. The first infusion occurs at the baseline visit, followed by a second infusion 14 days later at the same dose. This treatment period is followed by weekly clinic visits for six months to monitor participants responses and safety. During the study, participants will undergo regular assessments including viral load measurements, immunogenicity testing, and monitoring for adverse events from enrollment through 24 weeks after treatment starts. The researchers will track clinical symptoms and laboratory tests to evaluate treatment effects and safety over this period. The total participation duration extends up to six months with close follow-up care to observe outcomes and any treatment-related effects.

CONDITIONS

Brief Title

Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

Research Team

N

Nayoun Kim, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here